Moonkie's First Bites Gift Set Wins 'Tableware of the Year' at 2025 Baby Innovation Awards
Designed to Fit Real Family Life
The First Bites Gift Set is built with both function and everyday beauty in mind. With its clean design and soft, muted colors, it fits easily into modern homes—simple, practical, and calming to use.
The set includes everything needed to support a baby's first meals: a 3-in-1 sippy cup (that works as a straw, sippy, or open cup), a soft silicone bib with a deep pouch, a suction bowl and divided plate (both with lids), a flexible feeding spoon, a baby spoon and fork, two 4oz baby food containers with secure lids, and a silicone placemat. Every piece is designed to make feeding easier, whether at home or on the go.
Safe from the Start
When it comes to what your baby puts in their mouth, safety is non-negotiable. That's why every piece in the First Bites Gift Set is made from food-grade platinum silicone—no BPA, no phthalates, no harmful chemicals. The spoon and fork tips use medical-grade stainless steel, and everything is tested to meet strict US and EU safety standards.
As a parent, it means you don't have to second-guess what's touching your baby's food. No strong plastic smells, no weird coatings—just solid, safe materials you can trust, day after day. Whether you're serving warm oatmeal or chilled fruit, you know the tools you're using are built for your baby's health and peace of mind.
Less Mess, More Time for What Matters
Mealtimes with a baby are rarely neat—but this set helps make them manageable. The suction bowl and plate stay in place, so your baby can focus on eating instead of flipping dishes—and you don't have to clean the floor after every meal. The silicone bib catches food before it ends up on clothes or the chair, cutting down on outfit changes and laundry. When there are leftovers, the sealed containers make it easy to store or pack meals without leaks.
Built to Last, Easy to Clean
Babies drop things. They chew on everything. And they don't care if something gets thrown across the room. That's why every piece in the First Bites Gift Set is made to hold up to daily use—whether it's being tossed from a highchair or gnawed on during teething.
The flexible silicone doesn't crack or break, even after constant use. It's also stain-resistant, so you don't have to worry about colorful purees leaving a mess behind. And when mealtime is over, everything can go straight into the dishwasher—no scrubbing, no soaking.
Supports Baby's Growth and Independence
The 3-in-1 cup starts with a sippy lid, then transitions to a straw and eventually an open cup, so your baby can build confidence step by step. The soft-tipped spoon is gentle on sore gums and new teeth, while the utensils have easy-to-hold handles that encourage babies to try feeding themselves.
Whether you're doing purees or baby-led weaning, this set gives your little one the tools to practice eating independently—without making the process harder for you. It supports learning, builds coordination, and gives parents a small but meaningful break during mealtime.
A Gift That Feels Personal
Whether it's for a baby shower, a first birthday, or a milestone celebration, the First Bites Gift Set isn't just practical—it's deeply personal. Each set can be engraved with a child's name or initials and arrives in a luxe or standard gift box. It's a product that turns a daily ritual into a cherished memory.
An Award That Honors More Than Design
Being named 'Tableware of the Year' is a proud moment for Moonkie, It shows that parents today are looking for more than just baby gear. They want products that are safe, functional, and meaningful—tools that make life easier while respecting the moments that matter.
That's exactly what Moonkie stands for. Rooted in a balance of calm and curiosity, Moonkie designs with intention—creating everyday essentials that support real family life. From reducing mealtime stress to encouraging a child's independence, every product reflects a deep respect for early childhood and the little wins of parenthood.
Media Contact
Company Name: Moonkie
Contact Person: Lesley L.
Email: Send Email
Country: United States
Website: http://moonkieshop.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare
For Immediate Release Chicago, IL – August 4, 2025 – Today, Zacks Investment Ideas feature highlights CVS Health CVS, Johnson & Johnson JNJ and Tenet Healthcare THC. 3 Medical Stocks to Consider as Markets Take a Breather The broader indexes have cooled off in the last few trading sessions after what was another pleasant month for the stock market in July. While the market has been able to shrug off trade war concerns on the way to a historic rebound, President Trump has officially signed an executive order to hit most of the United States' trading partners with tariff hikes, which ignited a pullback on Friday as July's Jobs Report came in weaker than expected. Considering the benchmark S&P 500 and the tech-centric Nasdaq looked due for a breather after spiking more than +10% in the last three months, investors may be scoping out some defensive positions. That said, these medical sector stocks may continue to provide this defensive safety, as there will always be a constant need for health care. CVS Health Zacks Rank #2 (Buy) CVS Health's transformation into an innovative pharmacy company with integrated offerings across the entire spectrum of pharmacy care is paying off. Thanks to strong earnings, raised guidance, and renewed investor confidence, CVS stock has surged over +30% this year but still trades at just 10X forward earnings and offers a very generous 4.28% annual dividend yield. In addition to sporting a Zacks Rank #2 (Buy), CVS stock currently checks an overall 'A' VGM Zacks Style Scores grade for the combination of Value, Growth, and Momentum. Johnson & Johnson Zacks Rank #2 (Buy) Pharmaceutical giant Johnson & Johnson checks the value box, with a reasonable 15.1X forward earnings multiple and a 3.16% annual dividend yield. Furthermore, investors seemed to have flocked to Johnson & Johnson stock earlier in the year during heightened market volatility, and JNJ is still up +15% in 2025 to top the S&P 500 and Nasdaq's returns of roughly +7%. Although Johnson & Johnson's growth has slowed, steady top and bottom line expansion is still in the forecast, and the medical leader has one of the most diversified business models. Having more than 275 subsidiaries, Johnson & Johnson's pipeline of drugs/treatments covers neuroscience and mental health, oncology, immunology, pulmonary hypertension, cardiovascular, rare, and infectious diseases. Tenet Healthcare Zacks Rank #1 (Strong Buy) We'll round out the list with Tenet Healthcare, an investor-owned health care services company that owns and operates general hospitals and health care facilities for urban and rural communities in numerous states. Boasting a Zacks Rank #1 (Strong Buy), THC stock is benefiting from a very pleasant trend of positive earnings estimate revisions. With Tenet Healthcare's annual earnings now expected to leap 25% in fiscal 2025 to $14.92 per share, it's noteworthy that these EPS revisions have climbed 17% in the last 60 days from estimates of $12.69 two months ago. Plus, THC is up +25% YTD and trades at 10X forward earnings. Strongly suggesting Tenet Healthcare's impressive stock performance should continue, FY26 EPS is projected to expand another 4% to $15.48, and estimates have spiked 14% in the last 60 days. On top of being a 'feel-good' investment in regard to Tenet Healthcare reaching underserved communities, THC checks the fundamental trading boxes with an 'A' VGM Zacks Style Scores grade. Bottom Line Hopefully, the excitement for AI-driven growth will continue to push the broader market higher, but these top medical stocks can provide the defensive safety that investors may need with volatility starting to resurface amid President Trump's tariff hikes and last month's unfavorable jobs report. Why Haven't You Looked at Zacks' Top Stocks? Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year. Today you can access their live picks without cost or obligation. See Stocks Free >> Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Johnson & Johnson (JNJ): Free Stock Analysis Report CVS Health Corporation (CVS): Free Stock Analysis Report
Globe and Mail
2 hours ago
- Globe and Mail
Bear of the Day: Elevance Health (ELV)
Elevance Health ELV is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey. Analysts have taken a bearish stance on the company's outlook, landing the stock into a Zacks Rank #5 (Strong Sell). Let's take a closer look at how the company stacks up. ELV Faces Pressure ELV's latest set of quarterly results came in weak, causing shares to plunge post-earnings. The company trimmed its current year outlook, with ELV also falling short of the Zacks Consensus EPS estimate by more than 3%. Adjusted EPS fell 13% year-over-year, whereas sales of $49.4 billion grew 14% from the same period last year. Due to the ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid, ELV now expects 2025 adjusted EPS of $30.00, down big from the announced (and reaffirmed) guidance range of $34.15 - $34.85 given following the prior release near the beginning of May. The steep guidance cut this soon after a reaffirmation just near the beginning of May is certainly interesting. Below is a chart illustrating the company's sales on a quarterly basis. Bottom Line A big guidance cut paints a challenging picture for the company's shares in the near term. Elevance Health ELV is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company's earnings outlook. For those seeking strong stocks, the best idea would be to focus on stocks with a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy) – these stocks sport a notably stronger earnings outlook paired with the potential to deliver explosive gains in the near term. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Elevance Health, Inc. (ELV): Free Stock Analysis Report
CBC
4 hours ago
- CBC
My identical twin sister will always be my person, even as I medically transition
the FAQ. Being a twin means you're part of a unit. Although our parents worked hard to ensure we could grow as separate people, we were "the girls." For the longest time, that's how I understood myself and my identity: I was Camilla's sister. That's why when I sat down with my doctor to discuss gender-affirming care, the first thing I needed to say was that I'm an identical twin. While being a twin may seem unrelated to the fact that I'm trans, it has complicated my transition in ways I didn't anticipate. Many people were surprised when I came out as a trans man. Between Camilla and me, I was always the one who leaned a little more into the feminine side of things. When we were younger, around our early adolescence, Camilla was frequently mistaken for a boy because she cut her hair extremely short. I often found myself having to tell people, "This is my sister, Camilla, and she's a girl." I wonder sometimes if this is part of the reason it took so long for me to fully explore my gender. I can look back and recognize points in my childhood when I felt dysphoric, but it was oriented more towards my physical attributes and my body itself than the idea of femininity. The first person to learn that I was feeling gender dysphoria was Camilla. We were 17 and playing an online game during the pandemic. I had written in my profile that my pronouns were she/they to test them out and didn't think Camilla would notice. But she did, and while it was a surprise, she has always been the most supportive person in my life. Having her be the first to know made me feel more confident that I was on the right track. I wanted to approach transitioning slowly, so I focused on my social transition at first. When I considered going on hormones, I found myself hesitating. This was something I knew I wanted very badly, as it could potentially help a lot of the gender dysphoria I had been feeling for a long time. However, I knew that changing my body would change some of the things that made Camilla and me physically "identical." Identical is a strange word to use in our case, as we've always been pretty physically different in terms of hair, personal style and even mannerisms. But there was still a part of me that became anxious when I imagined, for example, sounding different from her. This was in contrast to the part of me that desperately wanted a lower voice — so much that I couldn't listen to certain songs that had my ideal voice. Wanting to remain an identical twin and also a different gender made it very difficult for me to take the step to medically transition. I felt I might sever my connection with Camilla if I took that step. I initially tried sorting out these feelings by reaching out to trans groups online. This ended up making me feel more isolated than anything else, as my situation is uncommon. The best advice I got in those groups was something I hadn't been brave enough to try, which was talking to Camilla about how I was feeling. While I had felt very isolated during this process, I found that I had no real reason to be. Somehow, I had forgotten that Camilla was, in all respects, my person and that even if she didn't entirely relate to my experience, she would understand and support me. Although it took me a long time after that to pursue hormones, Camilla encouraged me enthusiastically throughout the process and was thrilled for me when I finally got my prescription a year ago. I've found myself excited about the changes I thought would distance me from her, such as facial hair and more muscles. Her shared excitement has led me to realize that something like this could never drive a stake between us as I thought it might. Plus, she jokes that she gets to see what she would look like with a moustache and I get to see how my face would age had I never transitioned. At the same time, I treasure the things that make us similar, such as our eyes, our noses and our heights. It never makes me dysphoric to get mistaken for her or when people point out similarities. Although I'm very excited to be furthering my transition, I'm no longer afraid about living as my authentic self because my identity is and always will be tied to my twin. WATCH | Celebrating a centennial birthday with your twin: Newfoundland twins turn 100 3 years ago Mabel Dawe and Alice Clarke are twins who just turned 100-years-old.
